5LMY
Solution structure of the m-pmv myristoylated matrix protein
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | 2D 1H-15N HSQC | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
2 | 2D 1H-13C HSQC | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
3 | 3D CBCA(CO)NH | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
4 | 3D HNCACB | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
5 | 3D HBHA(CO)NH | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
6 | 3D HNCO | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
7 | 3D HN(CO)CA | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
8 | 3D HCCH-TOCSY | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
9 | 3D 1H-15N NOESY | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
10 | 3D 1H-13C NOESY | 1.2 mM [U-99% 13C; U-99% 15N] Matrix protein p10, 100 mM potassium phosphate, 300 mM sodium chloride, 5 mM DTT | 95% H2O/5% D2O | 600 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
11 | 2D 1H-15N HSQC IPAP | 0.2 mM [U-99% 15N] Matrix protein p10, 50 mM potassium phosphate, 150 mM sodium chloride, 5 mM DTT, 10 mg/mL Pf1 phage | 95% H2O/5% D2O | 300 mM | 6 | 1 atm | 298 | Bruker AvanceIII 600 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | AvanceIII | 600 |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | |
Conformers Calculated Total Number | |
Conformers Submitted Total Number | 15 |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | collection | TopSpin | 3.5 | Bruker Biospin |
2 | structure calculation | Xplor-NIH | 2.24 | Schwieters, Kuszewski, Tjandra and Clore |
3 | chemical shift assignment | CcpNmr Analysis | 2.1.5 | CCPN |
4 | geometry optimization | TALOS+ | Cornilescu, Delaglio and Bax |